UCL researchers have developed an ultrasound helmet that enables deep brain stimulation without surgery, offering hope for Parkinson's and other neurological disorders.
Peter Walker, CTO EMEA at Blue Prism, discusses how intelligent automation is being used by the NHS to streamline operations and improve patient outcomes, particularly in light of the COVID-19 crisis.
Alex Evans, UK Country Manager for ViCentra B.V., discusses how insulin pump system Kaleido can provide solutions to reduce the practical and emotional burden of living with diabetes.
COVID-19 has provided an all-too-real use case for video consultations in the NHS, but it’s the power it gives patients over their own care, that will ensure it survives long after the pandemic, says Rowan Pritchard Jones.
Finmark Sauna explores the health benefits associated with cardiovascular disease, mental health, pain and respiratory disease, of Finnish sauna bathing.
Dr Deborah Lee, Dr Fox Online Pharmacy, explores how aromatherapy is fast emerging as a form of alternative medicine for many health conditions, including insomnia.
Justin Hall, GM and VP EMEA, iRhythm Technologies, explores the impact that COVID-19 has had on the rapid scaling of new technology-enabled healthcare services.
Lord Victor Adebowale, chair and co-founder of Visionable, discusses why getting technology design right could be key to avoiding health inequity, especially during the COVID-19 crisis.
Researchers from the University of North Carolina and NC State have developed artificial beta cells that automatically release insulin into the bloodstream when glucose levels rise, leading the way for new diabetes treatment.
Professor Heather Sheardown, leader of Innovation Hub C20/20, discusses their research, innovation, and development of new biomaterials-based technologies to treat a variety of disorders in the eye.
Genevieve Leveille, CEO of UK firm 08 Group and Co-Chair of the TechUK DLT Working Group, collaborates with digital health tech companies to deliver verified-safe China-sourced Covid-19 test kits at scale.
Director of Product Management at Bioquell, Guy Turner, explains how RBDS uses Bioquell’s 35% hydrogen peroxide vapour solution to eliminate pathogens, thus providing a 6-log sporicidal kill and eliminating all traces of COVID-19.
Senior Accessibility Analyst at Digital Analyst Centre Mike Taylor discusses maximising technology to be both usable and accessible, and how to make it work for everyone.
